Atlas Trials

An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis

Clinical trial NCT05438342 · UNKNOWN

Trial details

NCT number
NCT05438342
Sponsor
Shanghai Pudong Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced CancerMetastatic Cancer
Start date
2021-11-01
Primary completion
2023-10-01
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.